ONCOSIL MEDICAL LTD (OSL)

---

AI Coverage Rating: Moderate

ASX AI Signals has generated 2 signal(s) for OSL during the last 90 days, indicating Moderate trading activity

Latest OSL Signals
10/06/2026	BUY
15/05/2026	SELL
27/03/2026	BUY
OSL Share Price
Current Price	$0.985
52 Week High	$1.985
52 Week Low:	$0.390
Trading at (% of 52 Week High)	49.62%

Business Overview

Oncosil Medical Ltd (ASX: OSL) is a medical technology company focused on developing and commercializing targeted radiation therapies for the treatment of cancer. Its main product, OncoSil, is a radiotherapy implant designed to improve outcomes for patients with pancreatic and other solid cancers. The company is based in Australia and operates internationally.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The BUY signal for ONCOSIL MEDICAL LTD at the current price of 0.5750 is supported by positive technical indicators and potential growth in the medical technology sector. However, the stock's volatility and limited market capitalization introduce moderate risk, warranting a cautious approach.

Latest  ONCOSIL MEDICAL LTD(OSL)   News